Choose AOD9604 if your primary goals are: Targeted Fat Reduction: If your main objective is to specifically target and reduce adipose tissue, particularly stubborn fat, and improve body composition, AOD9604's mechanism of action is more directly focused on these outcomes
BPC 157 and Standard Angiogenic Growth Factors
Food and Drug Administration (FDA), and are not intended to diagnose, treat, cure, or prevent any disease or medical condition
But for those looking to take it a step further, peptides are proving to be powerful allies in reshaping the body in ways that diet and exercise alone may not achieve
As of June 2026, tirzepatide is FDA-approved (Zepbound, Mounjaro) and CagriSema is not